The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers

Autor: Jessica Castro Flores, Sandra Inglés Borda, Manuel Fernández Martínez, M.C. González-Fernández, María Carrasco Zabaleta, Miryam Barandiarán Amillano, María Ángeles Gómez Beldarraín, Josefa Moraza López, Marian M. de Pancorbo, Xabier Elcoroaristizabal Martín, Begoña Indakoetxea Juanbeltz, Rocio Bereincua Gandarias, Ana Molano Salazar, Nuria Ortiz Marqués, Luis Galdos Alcelay, Juan María Uterga Valiente

Publikováno v: BMC Neuroscience
Addi. Archivo Digital para la Docencia y la Investigación
instname
BMC Neuroscience, Vol 10, Iss 1, p 125 (2009)

Background: The aim of this study is to examine the influence of the catechol-O-methyltranferase (COMT) gene (polymorphism Val158 Met) as a risk factor for Alzheimer's disease (AD) and mild cognitive impairment of amnesic type (MCI), and its synergis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b98f405cdc372edb37acdbf9f375f65c
https://doi.org/10.1186/1471-2202-10-125